Unknown

Dataset Information

0

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.


ABSTRACT: OBJECTIVES: It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. METHODS: This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. Cases experienced virological failure and controls were subjects from the same cohort whose viraemia remained suppressed at a matched time since initiation of ART. Blinded, centralized 454 pyrosequencing with parallel bioinformatic analysis in two laboratories was used to identify MVs in the 1%-25% frequency range. ORs of virological failure according to MV detection were estimated by logistic regression. RESULTS: Two hundred and sixty samples (76 cases and 184 controls), mostly subtype B (73.5%), were used for the analysis. Identical MVs were detected in the two laboratories. 31.6% of cases and 16.8% of controls harboured pre-existing MVs. Detection of at least one MV versus no MVs was associated with an increased risk of virological failure (OR?=?2.75, 95% CI?=?1.35-5.60, P?=?0.005); similar associations were observed for at least one MV versus no NRTI MVs (OR?=?2.27, 95% CI?=?0.76-6.77, P?=?0.140) and at least one MV versus no NNRTI MVs (OR?=?2.41, 95% CI?=?1.12-5.18, P?=?0.024). A dose-effect relationship between virological failure and mutational load was found. CONCLUSIONS: Pre-existing MVs more than double the risk of virological failure to first-line NNRTI-based ART.

SUBMITTER: Cozzi-Lepri A 

PROVIDER: S-EPMC4319483 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objectives</h4>It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART.<h4>Methods</h4>This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. Cases experienced virological failure and controls were subjects from the same cohort whose viraemia r  ...[more]

Similar Datasets

| S-EPMC4234478 | biostudies-literature
| S-EPMC3605598 | biostudies-literature
| S-EPMC3194189 | biostudies-literature
| S-EPMC3017093 | biostudies-literature
| S-EPMC3954088 | biostudies-literature
| S-EPMC3788733 | biostudies-literature
| S-EPMC3116506 | biostudies-literature
| S-EPMC2763888 | biostudies-literature
| S-EPMC2748093 | biostudies-literature
| S-EPMC4105287 | biostudies-literature